摘要
医药制造企业产品(药品)创新会带来巨大的经济效益和社会效益,药企如何在技术领域平衡竞争与合作的双元关系以提升产品创新绩效,成为学界和业界普遍关注的议题。在改进传统机械平衡法的基础上,采用有机平衡法探究企业技术竞合平衡对产品创新绩效的作用,以2007~2022年沪深两市215家医药制造企业为样本,运用面板负二项模型进行实证检验。研究结果发现:医药制造企业平衡技术竞争与技术合作两种矛盾关系不仅会产生机会主义风险,还会消耗组织资源、挤占产品创新所需资源,导致技术竞合平衡与产品创新绩效存在显著的负向关系;严格的地区知识产权保护将提高药品侵权成本,抑制竞合伙伴的机会主义行为,地区知识产权保护显著削弱了医药制造企业技术竞合平衡与产品创新绩效之间的负向关系。
Product(drug)innovation in pharmaceutical manufacturing firms will bring enormous economic and social benefits.How to balance the ambivalent relationship between competition and cooperation in the technology field to improve product innovation performance has become a topic of widespread concern in academia and industry.On the basis of improving the traditional mechanical balance method,the organic balance method was used to explore the effect of technology coopetition balance on product innovation performance.A total of 215 pharmaceutical manufacturing firms in Shanghai and Shenzhen stock exchange market from 2007 to 2022 were selected as samples,and the panel negative binomial model was used to empirically test the research hypotheses.The results showed that balancing the two contradictory relationships between technology competition and technical cooperation in pharmaceutical manufacturing firms will not only produce opportunistic risks,but also consume organizational resources and squeeze out the resources required for product innovation,resulting in a significant negative relationship between technology competition and cooperation balance and product innovation performance.Strict regional intellectual property rights protection will increase the cost of drug infringement,suppress opportunistic behavior of competing partners,and regional intellectual property rights protection will significantly weaken the negative relationship between the balance of technology competition and cooperation and the performance of product innovation in pharmaceutical manufacturing firms.
作者
张晓飞
孙玉涛
张晨
ZHANG Xiaofei;SUN Yutao;ZHANG Chen(School of Economics and Management,Dalian University of Technology,Dalian 116024,China)
出处
《大连理工大学学报（社会科学版）》
北大核心
2024年第4期60-69,共10页
Journal of Dalian University of Technology(Social Sciences)
基金
国家社会科学基金重大项目“新形势下我国科技创新治理体系现代化研究”(20&ZD074)。
关键词
医药制造企业
技术竞合平衡
产品创新绩效
地区知识产权保护
Pharmaceutical manufacturing firms
Balance of technology competition and cooperation
Product innovation performance
Regional intellectual property rights protection
